Trials / Completed
CompletedNCT04874142
Phase 1 to Evaluate the Safety and Pharmacokinetic Durg-drug Interaction of YYC506-T and YYC506-A
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Yooyoung Pharmaceutical Co., Ltd. · Industry
- Sex
- Male
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the safety and pharmacokinetics drug-drug interaction of YYC506-T and YYC506-A
Detailed description
Phase 1 to evaluate the safety and pharmacokinetics drug-drug interaction of YYC506-T and YYC506-A. Which is designed as two cohort, single-sequence, paralle, open label, multiple oral dosing.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | YYC506-T | single administration |
| DRUG | YYC506-A | single administration |
| DRUG | YYC506-T + YYC506-A | concomotant administration |
| DRUG | YYC506-A + YYC506-T | concomotant administration |
Timeline
- Start date
- 2019-11-20
- Primary completion
- 2020-03-23
- Completion
- 2020-03-23
- First posted
- 2021-05-05
- Last updated
- 2021-05-05
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04874142. Inclusion in this directory is not an endorsement.